World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
28685
World Ranking
1113
National Ranking
38

Eric Tartour publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eric Tartour sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 366 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eric Tartour D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eric Tartour sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eric Tartour is affiliated with Université Paris Cité in France and has conducted research primarily in the fields of Medicine and Immunology and Microbiology. Their work focuses extensively on areas such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, and SARS-CoV-2 and COVID-19 Research.

Their research covers several specialized topics including:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research
  • Immune cells in cancer

Eric Tartour's frequent publication venues reflect a strong presence in both preprint and peer-reviewed journals, with multiple papers appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Bulletin de l Académie Nationale de Médecine
  • Nature Medicine
  • Nature Communications
  • Immunity & Ageing

The scientist has collaborated several times with some researchers including Nadine Benhamouda, Odile Launay, Xavier de Lamballerie, Thi Tran, and Alain Gey, indicating a network of frequent co-authors across their projects.

Among their recent papers are:

  • "Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review," 2021, Clinical Microbiology and Infection
  • "T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours," 2021, Nature Biomedical Engineering
  • "PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study," 2020, The Lancet Infectious Diseases
  • "CXCR6 expressing T cells: Functions and role in the control of tumors," 2022, Frontiers in Immunology
  • "CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors," 2021, Journal for ImmunoTherapy of Cancer

Their work frequently intersects with oncology and infectious diseases, with subfields of study including Immunology, Oncology, Infectious Diseases, Molecular Biology, and Pulmonary and Respiratory Medicine. This cross-disciplinary approach aligns with their contributions in cancer immunotherapy and responses to infectious agents like SARS-CoV-2.

Best Publications

  • Immune infiltration in human tumors: a prognostic factor that should not be ignored.

    Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E

  • VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

    Thibault Voron;Orianne Colussi;Elie Marcheteau;Simon Pernot

  • Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

    Marie-Caroline Dieu-Nosjean;Martine Antoine;Claire Danel;Didier Heudes

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

    Magali Terme;Simon Pernot;Elie Marcheteau;Federico Sandoval

  • PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

    Cécile Badoual;Stéphane Hans;Nathalie Merillon;Cordélia Van Ryswick

  • Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

    Cécile Badoual;Stéphane Hans;José Rodriguez;Severine Peyrard

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report

    Philippe Menasché;Philippe Menasché;Valérie Vanneaux;Albert Hagège;Albert Hagège;Alain Bel

  • Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

    Fabrice Benchetrit;Arnaud Ciree;Virginie Vives;Guy Warnier

  • Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates

    Wolf Herman Fridman;Jérôme Galon;Franck Pagès;Eric Tartour

  • Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

    Philippe Menasché;Valérie Vanneaux;Albert Hagège;Alain Bel

  • Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

    Eric Tartour;François Fossiez;Isabelle Joyeux;Annie Galinha

  • IL-18 induces PD-1-dependent immunosuppression in cancer.

    Magali Terme;Evelyn Ullrich;Laetitia Aymeric;Kathrin Meinhardt

  • Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

    Eric Tartour;H. Pere;B. Maillere;M. Terme

  • Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer.

    Clemence Granier;Eleonore De Guillebon;Charlotte Blanc;Helene Roussel

  • Control of the immune response by pro-angiogenic factors.

    Thibault Voron;Elie Marcheteau;Simon Pernot;Orianne Colussi

  • Resident memory T cells, critical components in tumor immunology

    Fathia Mami-Chouaib;Charlotte Blanc;Stéphanie Corgnac;Sophie Hans

  • Trial watch: IDO inhibitors in cancer therapy

    Erika Vacchelli;Fernando Aranda;Alexander Eggermont;Catherine Sautès-Fridman

  • Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control

    Wolf H. Fridman;Jérome Galon;Jérome Galon;Marie-Caroline Dieu-Nosjean;Marie-Caroline Dieu-Nosjean;Isabelle Cremer;Isabelle Cremer

Frequent Co-Authors

Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Ludger Johannes
Ludger Johannes Institute Curie
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Guido Kroemer
Guido Kroemer Université Paris Cité
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Isabelle Cremer
Isabelle Cremer Sorbonne University
Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
Julien Taieb
Julien Taieb Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and its applications in healthcare, pursuing advanced nursing degrees can open rewarding career avenues. Many students seek out the easiest nurse practitioner program options, which provide flexible online formats to balance rigorous study with personal commitments.

Specializing as a Psychiatric Mental Health Nurse Practitioner (PMHNP) is another promising pathway, especially with programs known for their top psychiatric mental health nurse practitioner programs online that offer excellent clinical placement opportunities. These programs emphasize clinical experience vital for treating patients with complex immunological and mental health issues.

Cost is often a major factor. Prospective students can find quality education through the cheapest psychiatric nurse practitioner programs, making advanced nursing degrees more accessible without compromising on the quality of training.

Career prospects remain strong, as reflected in earning potential. Understanding how much do dnps make can help students evaluate the return on investment for pursuing Doctor of Nursing Practice (DNP) degrees, including those related to immunology and mental health specialties.

Best Scientists Citing Eric Tartour

Trending Scientists

Recently Published Articles